This agrees with previous studies in SCLC, where the JAK/STAT pathway has been shown to be involved in DNA damage resistance upon chemo- and radiotherapy through activation of U-ISGF3-inducible genes [16]. This evidence concerns the gene SOAT1 and small cell lung carcinoma.